Catherine Novack
Stock Analyst at Jones Trading
(1.66)
# 3,196
Out of 4,761 analysts
17
Total ratings
33.33%
Success rate
-8.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.56 | +329.69% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $26.29 | +394.48% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $15.00 | +166.67% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.88 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $11.13 | +43.76% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.19 | +338.87% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $3.17 | +310.09% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $1.31 | +510.69% | 1 | May 31, 2024 | |
| RZLT Rezolute | Initiates: Buy | $10 | $4.53 | +120.75% | 1 | Apr 18, 2024 | |
| FEMY Femasys | Maintains: Buy | $7 → $10 | $1.64 | +509.76% | 1 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.35 | +836.17% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.05 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $3.17 | +4,947.32% | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.16 | +6,779.30% | 1 | Mar 10, 2023 |
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.56
Upside: +329.69%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $26.29
Upside: +394.48%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $15.00
Upside: +166.67%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.88
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $11.13
Upside: +43.76%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.19
Upside: +338.87%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $3.17
Upside: +310.09%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.31
Upside: +510.69%
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.53
Upside: +120.75%
Femasys
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.64
Upside: +509.76%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $2.35
Upside: +836.17%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.05
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $3.17
Upside: +4,947.32%
Mar 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.16
Upside: +6,779.30%